相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension
Marius M. Zucker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
NLRC3 inhibits MCT-induced pulmonary hypertension in rats via attenuating PI3K activation
Li-Huang Zha et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in pulmonary Arteria Hypenension
Alice Bourgeois et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Astrid Weiss et al.
NATURE COMMUNICATIONS (2019)
PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension
Laszlo Kovacs et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension
Zhiyu Dai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension
Giada Zurlo et al.
JOURNAL OF HYPERTENSION (2018)
Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats
Ruizan Shi et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway
Jingbo Dai et al.
NATURE COMMUNICATIONS (2018)
NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension Diagnosis
Li-huang Zha et al.
AGING AND DISEASE (2018)
Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
Kimio Satoh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
Haiyang Tang et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Pulmonary vascular remodeling in pulmonary hypertension
Rubin M. Tuder
CELL AND TISSUE RESEARCH (2017)
Pathology and Pathobiology of Pulmonary Hypertension
Christophe Guignabert et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension
A. A. Roger Thompson et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling
Gesheng Cheng et al.
STEM CELL RESEARCH & THERAPY (2017)
NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer
Rajendra Karki et al.
CELL CYCLE (2017)
PI3K and Calcium Signaling in Cardiovascular Disease
Alessandra Ghigo et al.
CIRCULATION RESEARCH (2017)
Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension
Yuansheng Gao et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer
Rajendra Karki et al.
NATURE (2016)
Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms
Yang Song et al.
PHARMACOLOGICAL RESEARCH (2016)
Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
Jane A. Leopold et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension
Amil M. Shah et al.
EUROPEAN HEART JOURNAL (2015)
Targeting cell motility in pulmonary arterial hypertension
Roxane Paulin et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Amal Houssaini et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways
Ping Yuan et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension
Matthew Thomas et al.
PHARMACOLOGY & THERAPEUTICS (2013)
BDNF/TrkB Signaling Augments Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Grazyna Kwapiszewska et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Hypoxia Enhances Platelet-derived Growth Factor Signaling in the Pulmonary Vasculature by Down-Regulation of Protein Tyrosine Phosphatases
Henrik ten Freyhaus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
CATERPILLER 16.2 (CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function
BJ Conti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis
MS McMurtry et al.
CIRCULATION RESEARCH (2004)
分享论文
